BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16630572)

  • 1. Bromovinyl-deoxyuridine: A selective substrate for mitochondrial thymidine kinase in cell extracts.
    Franzolin E; Rampazzo C; Pérez-Pérez MJ; Hernández AI; Balzarini J; Bianchi V
    Biochem Biophys Res Commun; 2006 May; 344(1):30-6. PubMed ID: 16630572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Bromovinyl 2'-deoxyuridine phosphorylation by mitochondrial and cytosolic thymidine kinase (TK2 and TK1) and its use in selective measurement of TK2 activity in crude extracts.
    Wang L; Eriksson S
    Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):858-62. PubMed ID: 18600552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues.
    Arnér ES; Spasokoukotskaja T; Eriksson S
    Biochem Biophys Res Commun; 1992 Oct; 188(2):712-8. PubMed ID: 1359886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unchanged thymidine triphosphate pools and thymidine metabolism in two lines of thymidine kinase 2-mutated fibroblasts.
    Frangini M; Rampazzo C; Franzolin E; Lara MC; Vilà MR; Martí R; Bianchi V
    FEBS J; 2009 Feb; 276(4):1104-13. PubMed ID: 19154348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate/inhibitor properties of human deoxycytidine kinase (dCK) and thymidine kinases (TK1 and TK2) towards the sugar moiety of nucleosides, including O'-alkyl analogues.
    Kierdaszuk B; Krawiec K; Kazimierczuk Z; Jacobsson U; Johansson NG; Munch-Petersen B; Eriksson S; Shugar D
    Nucleosides Nucleotides; 1999 Aug; 18(8):1883-903. PubMed ID: 10478487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of human mitochondrial thymidine kinase in Escherichia coli: correlation between the enzymatic activity of pyrimidine nucleoside analogues and their inhibitory effect on bacterial growth.
    Wang J; Su C; Neuhard J; Eriksson S
    Biochem Pharmacol; 2000 Jun; 59(12):1583-8. PubMed ID: 10799656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides.
    Munch-Petersen B; Cloos L; Tyrsted G; Eriksson S
    J Biol Chem; 1991 May; 266(14):9032-8. PubMed ID: 2026611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tracking cellular stress with labeled FMAU reflects changes in mitochondrial TK2.
    Tehrani OS; Douglas KA; Lawhorn-Crews JM; Shields AF
    Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1480-8. PubMed ID: 18265975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retained sensitivity to cytotoxic pyrimidine nucleoside analogs in thymidine kinase 2 deficient human fibroblasts.
    Bjerke M; Solaroli N; Lesko N; Balzarini J; Johansson M; Karlsson A
    Nucleosides Nucleotides Nucleic Acids; 2010 Jan; 29(1):1-13. PubMed ID: 20391188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in thymidine kinase 2 (TK2) inhibitors and new perspectives for potential applications.
    Priego EM; Karlsson A; Gago F; Camarasa MJ; Balzarini J; Pérez-Pérez MJ
    Curr Pharm Des; 2012; 18(20):2981-94. PubMed ID: 22571666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of the anti-hepatitis B nucleoside analog 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil (FIAU) by human cytosolic and mitochondrial thymidine kinase and implications for cytotoxicity.
    Wang J; Eriksson S
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1555-7. PubMed ID: 8726039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relaxed enantioselectivity of human mitochondrial thymidine kinase and chemotherapeutic uses of L-nucleoside analogues.
    Verri A; Priori G; Spadari S; Tondelli L; Focher F
    Biochem J; 1997 Nov; 328 ( Pt 1)(Pt 1):317-20. PubMed ID: 9359870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. siRNA knockdown of mitochondrial thymidine kinase 2 (TK2) sensitizes human tumor cells to gemcitabine.
    Di Cresce C; Figueredo R; Rytelewski M; Maleki Vareki S; Way C; Ferguson PJ; Vincent MD; Koropatnick J
    Oncotarget; 2015 Sep; 6(26):22397-409. PubMed ID: 26087398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate specificity of feline and canine herpesvirus thymidine kinase.
    Solaroli N; Johansson M; Persoons L; Balzarini J; Karlsson A
    Antiviral Res; 2008 Aug; 79(2):128-32. PubMed ID: 18455811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate/inhibitor specificities of human deoxycytidine kinase (dCK) and thymidine kinases (TK1 and TK2).
    Kierdaszuk B; Krawiec K; Kazimierczuk Z; Jacobsson U; Johansson NG; Munch-Petersen B; Eriksson S; Shugar D
    Adv Exp Med Biol; 1998; 431():623-7. PubMed ID: 9598140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbocyclic 5-iodo-2'-deoxyuridine (C-IDU) and carbocyclic (E)-5-(2-bromovinyl)-2'-deoxyuridine (C-BVDU) as unique examples of chiral molecules where the two enantiomeric forms are biologically active: interaction of the (+)- and (-)-enantiomers of C-IDU and C-BVDU with the thymidine kinase of herpes simplex virus type 1.
    Balzarini J; De Clercq E; Baumgartner H; Bodenteich M; Griengl H
    Mol Pharmacol; 1990 Mar; 37(3):395-401. PubMed ID: 2156153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial thymidine kinase 2 but not deoxyguanosine kinase is up-regulated during the stationary growth phase of cultured cells.
    Sun R; Eriksson S; Wang L
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):282-6. PubMed ID: 24940680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deoxyribonucleoside kinases belonging to the thymidine kinase 2 (TK2)-like group vary significantly in substrate specificity, kinetics and feed-back regulation.
    Knecht W; Petersen GE; Munch-Petersen B; Piskur J
    J Mol Biol; 2002 Jan; 315(4):529-40. PubMed ID: 11812127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multifunctional deoxynucleoside kinase of insect cells is a target for the development of new insecticides.
    Balzarini J; Degrève B; Hatse S; De Clercq E; Breuer M; Johansson M; Huybrechts R; Karlsson A
    Mol Pharmacol; 2000 Apr; 57(4):811-9. PubMed ID: 10727530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability and cytosolic kinases modulate response to deoxynucleoside therapy in TK2 deficiency.
    Lopez-Gomez C; Hewan H; Sierra C; Akman HO; Sanchez-Quintero MJ; Juanola-Falgarona M; Tadesse S; Tanji K; Konofagou EE; Hirano M
    EBioMedicine; 2019 Aug; 46():356-367. PubMed ID: 31383553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.